Status:
COMPLETED
Comparison of Human Papillomavirus Integrated DNA and Messenger RNA in Cervical Neoplasia
Lead Sponsor:
Cathay General Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
20-80 years
Brief Summary
The investigators hypothesis is HPV integration could result in expression of oncogene transcripts, and not only constitutive expression but also the level of expression will be decisive for transform...
Detailed Description
In the investigators proposal, the investigators will examine at least 250 baseline liquid-based cytology specimens from women with normal cytology, low-grade squamous intraepithelial lesions (LSILs),...
Eligibility Criteria
Inclusion
- cervical neoplasia
- HPV infection patient
Exclusion
- no HPV infection
- no intra-epithelial neoplasia lesion
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT02198365
Start Date
January 1 2007
End Date
March 1 2009
Last Update
July 23 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cathay General Hospital
Taipei, Taiwan, 10630